GE Healthcare: Revenue Growth, Margin Expansion And Attractive Valuation
Summary
- GEHC was spun off from GE almost a year ago, and its stock price is almost back to where it started.
- The company has great revenue prospects and an opportunity to expand margins and improve profitability.
- It is trading at depressed multiples compared to its peers, and we think it can compound money at a 22% CAGR over the next three years.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.